....+28%.
I've only been saying this approval overdue now for 3 months now. For once I have little sympathy for those who sold before this, so tired am I for the crap thrown at me on here, despite the information and research I post.
Well done to the patient believers who topped on the waning lows. This probably has some room to run in coming days, Insto's started buying in in on CelGro Nerve a couple of years ago. TGA approval a big overdue re-rate event. Now onto FDA approval, in which the company is again overdue news, having passed the required 501K study, but deciding to explore a more lucrative 'De Novo' or other regulatory approval route with the FDA.
Ann: Regulatory Approval for Remplir Nerve Repair Device, page-8
-
- There are more pages in this discussion • 104 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add OCC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
38.5¢ |
Change
0.005(1.32%) |
Mkt cap ! $80.59M | |||
| Open | High | Low | Value | Volume |
| 40.0¢ | 40.0¢ | 38.0¢ | $24.44K | 62.27K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 10000 | 38.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 38.5¢ | 649 | 1 |
View Market Depth
| Last trade - 16.10pm 26/07/2024 (20 minute delay) ? |
| OCC (ASX) Chart |